Kinerja vs S&P 500

03
Dilacak Q1 2025–Q2 2026 +800.9%
Total imbal hasil S&P 500 (jendela yang sama) +37.0%
Imbal hasil berlebih +763.9%

Tahunan: +481.0% · S&P 500: +28.7%

Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.

Cakupan yang dapat dihargai: 99,1% · Opsi dikecualikan: 0,0%

Rincian sektor

04
Healthcare 92,0%
Lainnya/Tidak terpetakan 8,0%

Portofolio lengkap 35 posisi

05
Tipe Rentetan Tren 8 kuartal
Penerbit tidak dikenal (CUSIP: 22978P205) $1.670.408 7,99% 52.928 Naik ×1
PRAX Praxis Precision Medicines, Inc. - Common Stock $1.489.816 7,13% 4.450 $56.070
MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares $1.314.225 6,29% 67.500 $56.025
FENC Fennec Pharmaceuticals Inc. - Common Stock $1.208.666 5,78% 112.434 $517.197
RPRX Royalty Pharma plc - Class A Ordinary Shares $1.199.898 5,74% 21.400 $173.340
CMPS COMPASS Pathways Plc - American Depository Shares $1.132.000 5,41% 80.000 $689.600
MIST Milestone Pharmaceuticals Inc. - Common Shares $1.098.800 5,26% 820.000 $123.000
BNTC Benitec Biopharma Inc. - Common Stock $829.560 3,97% 62.000 $169.260
SNDX Syndax Pharmaceuticals, Inc. - Common Stock $786.960 3,76% 36.000 $-54.000
BHVN Biohaven Ltd. Common Shares $769.296 3,68% 51.700 $331.914
GERN Geron Corporation - Common Stock $739.840 3,54% 578.000 $-121.380
QURE uniQure N.V. - Ordinary Shares $677.082 3,24% 14.700 $436.737
ARDX Ardelyx, Inc. - Common Stock $656.115 3,14% 128.650 $-114.499
LNTH Lantheus Holdings, Inc. - Common Stock $610.170 2,92% 5.500 $192.995
IRON Disc Medicine, Inc. - Common Stock $592.434 2,83% 8.100 $74.520
SRPT Sarepta Therapeutics, Inc. - Common Stock $512.145 2,45% 28.500 $-108.015
HUMA Humacyte, Inc. - Common Stock $507.260 2,43% 650.000 $112.905
KURA Kura Oncology, Inc. - Common Stock $504.620 2,41% 46.000 $130.640
VTRS Viatris Inc. - Common Stock $439.876 2,10% 27.700 $65.649
DYN Dyne Therapeutics, Inc. - Common Stock $399.780 1,91% 18.000 $73.440
BBIO BridgeBio Pharma, Inc. - Common Stock $372.400 1,78% 5.000 $1.100
EWTX Edgewise Therapeutics, Inc. - Common Stock $369.733 1,77% 9.100 $83.083
PCRX Pacira BioSciences, Inc. - Common Stock $342.495 1,64% 13.500 $37.395
RGNX REGENXBIO Inc. - Common Stock $318.668 1,52% 26.600 $95.760
RCKT Rocket Pharmaceuticals, Inc. - Common Stock $294.120 1,41% 86.000 $-13.760
JANX Janux Therapeutics, Inc. - Common Stock $291.840 1,40% 19.000 $27.740
MLYS Mineralys Therapeutics, Inc. - Common Stock $283.290 1,36% 10.500 $-1.155
GHRS GH Research PLC - Ordinary Shares $274.176 1,31% 10.200 $130.764
MCRB Seres Therapeutics, Inc. - Common Stock $249.087 1,19% 31.570 $-30.939
AZTA Azenta, Inc. - Common Stock $247.544 1,18% 9.700 $42.583
JSPR Jasper Therapeutics, Inc. - Class A Common Stock $195.765 0,94% 465.000 $-211.668
INVA Innoviva, Inc. - Common Stock $186.222 0,89% 8.200 $-4.838
IPHA Innate Pharma S.A. - American Depositary Shares $149.318 0,71% 81.151 $45.445
ARQT Arcutis Biotherapeutics, Inc. - Common stock $137.655 0,66% 5.250 $13.965
SPRB Spruce Biosciences, Inc. - Common Stock $54.000 0,26% 1.000 $-11.350

Taruhan baru terbesar

09

Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.

SekuritasNilaiSaham% dari portofolio
Penerbit tidak dikenal (CUSIP: 22978P205) $1.670.408 52.928 7,99%

Penggerak teratas (QoQ)

10
SekuritasAksiSaham ΔNilai Δ
CMPS Hanya pergerakan harga +0 +$690K
FENC Hanya pergerakan harga +0 +$517K
QURE Hanya pergerakan harga +0 +$437K
BHVN Hanya pergerakan harga +0 +$332K
JSPR Hanya pergerakan harga +0 -$212K
LNTH Hanya pergerakan harga +0 +$193K
RPRX Hanya pergerakan harga +0 +$173K
BNTC Hanya pergerakan harga +0 +$169K
GHRS Hanya pergerakan harga +0 +$131K
KURA Hanya pergerakan harga +0 +$131K

Posisi yang keluar

11

Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan

Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.

SekuritasKuartalSaham sebelumnyaNilai sebelumnyaHarga sejak keluar
AVDL 31 Des. 2025 59.700 $911.619 Tidak lagi dilacak
KNSA 31 Des. 2025 23.400 $908.622 86,9%
INSM 31 Des. 2025 6.250 $900.063 -39,5%
CUE 30 Juni 2026 2.202.854 $506.436 -26,7%
DAWN 31 Maret 2026 42.000 $391.440 Tidak lagi dilacak
BLUE 30 Juni 2025 78.912 $385.091 Tidak lagi dilacak
VTYX 31 Maret 2026 41.500 $374.745 Tidak lagi dilacak
NERV 31 Maret 2026 35.000 $140.700 -43,1%
SPRB 30 Juni 2025 75.000 $21.758 -89,6%
MRSN 31 Maret 2026 100 $2.893 Tidak lagi dilacak